Doctors say Eli Lilly's weight loss pills will have a profound impact

Eli Lilly’s weight loss drug Orforglipron showed a 11.2% weight loss effect in a large clinical trial, with side effects comparable to current injection therapy, which is what doctors said at the European Association for Research on Diabetes (EAD) meeting. The full data for the trial has been released in the New England Journal of Medicine.